Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.

PURPOSE: The origin licensing factors minichromosome maintenance 2 (Mcm2) and Geminin have recently been identified as critical regulators of growth and differentiation. Here we have investigated the regulation of these licensing factors together with Ki67 to further elucidate the cell cycle kineti...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Dudderidge, T, Stoeber, K, Loddo, M, Atkinson, G, Fanshawe, T, Griffiths, D, Williams, G
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2005

Gelijkaardige items

Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells.
door: Kingsbury, SR, et al.
Gepubliceerd in: (2005)

Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
door: Nurhan Güler, et al.
Gepubliceerd in: (2012-01-01)

Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
door: Marzena Podhorska-Okolow, et al.
Gepubliceerd in: (2010-11-01)

MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors
door: Ritika Raja, et al.
Gepubliceerd in: (2021-01-01)

MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma
door: Zohreh Jaafari-Ashkavandi, et al.
Gepubliceerd in: (2019-01-01)

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
door: Arisa Nishimukai, et al.
Gepubliceerd in: (2017-01-01)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
door: I. Pergolini, et al.
Gepubliceerd in: (2019-10-01)

Gene experison of cell proliferative marker Ki67 in breast cancer
door: Golmohammadi R (PhD), et al.
Gepubliceerd in: (2011-09-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
door: Christina Marouda, et al.
Gepubliceerd in: (2024-01-01)

Evaluation of Nuclear Morphometry and Ki-67 Proliferative Marker in Astrocytomas: An Ambispective Study
door: Palak Nanda, et al.
Gepubliceerd in: (2023-01-01)

A study on the role of proliferative index marker Ki67 in breast carcinoma
door: Vijetha Vikram, et al.
Gepubliceerd in: (2022-11-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
door: Nasrin Shayanfar, et al.
Gepubliceerd in: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
door: Nasrin Shayanfar, et al.
Gepubliceerd in: (2010-05-01)

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
door: Huberman Joel, et al.
Gepubliceerd in: (2006-08-01)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
door: Muhammad Zain Mehdi, et al.

Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67
door: Ramesh Babu Telugu, et al.
Gepubliceerd in: (2016-01-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
door: Gasperetti F, et al.
Gepubliceerd in: (2011-03-01)

Expression of proliferative marker Ki-67 in epithelial dysplasia and squamous cell carcinoma of oral cavity
door: Payal Doctor, et al.
Gepubliceerd in: (2023-04-01)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
door: Bachmann Ingeborg M, et al.
Gepubliceerd in: (2010-04-01)

Comment on “PCNA and Ki67: Prognostic proliferation markers for oral cancer”
door: Muthupandian Saravanan
Gepubliceerd in: (2024-06-01)

Expression of Ki67 as a Prognostic Marker in Invasive Breast Carcinoma
door: Rashi Ahuja, et al.
Gepubliceerd in: (2017-07-01)

Association of degree of expression of ki 67 proliferative cell marker with aggressive giant cell tumor of the bone
door: Wan Faisham Nu Man, Wan Ismail
Gepubliceerd in: (2013)

Geminin is required for the maintenance of pluripotency.
door: Golnaz A Tabrizi, et al.
Gepubliceerd in: (2013-01-01)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
door: Dorsay Sadeghian, et al.
Gepubliceerd in: (2022-02-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
door: Fahimeh Rezazadeh, et al.
Gepubliceerd in: (2017-09-01)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
door: G.S. Starodub, et al.
Gepubliceerd in: (2016-04-01)

The expression of Ki-67 marker in the hydatidiform mole
door: Ecaterina Carpenco, et al.
Gepubliceerd in: (2022-12-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
door: Fatima S. Al-Sarraf, et al.
Gepubliceerd in: (2015-07-01)

The importance of prognostic markers of tumor progression Ki-67 and р53 in the breast cancer
door: Bondareva V.A., et al.
Gepubliceerd in: (2007-01-01)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
door: Yunbao Pan, et al.
Gepubliceerd in: (2017-01-01)

Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
door: Larissa Cardoso Marinho, et al.
Gepubliceerd in: (2005-12-01)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
door: Dudderidge, T, et al.
Gepubliceerd in: (2007)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
door: Agnieszka Pinkowska, et al.
Gepubliceerd in: (2021-12-01)

Predictive Role of Ki-67 and Proliferative-Cell Nuclear Antigen (PCNA) in Recurrent Cholesteatoma
door: Ela Araz Server, et al.
Gepubliceerd in: (2019-04-01)

Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
door: Marković Olivera, et al.
Gepubliceerd in: (2005-01-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
door: T. A. Bogush, et al.
Gepubliceerd in: (2023-07-01)

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
door: Mojca Založnik, et al.
Gepubliceerd in: (2024-07-01)

Role of Proliferative Marker (Ki-67) and ER, PR in Cervical Epithelial Lesions with Clinicopathological Association: A Cross-sectional Study
door: Shrabani Mitra, et al.
Gepubliceerd in: (2025-02-01)

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
door: Sarocha Vivatvakin, et al.
Gepubliceerd in: (2021-07-01)

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma
door: Betül Bolat Küçükzeybek, et al.
Gepubliceerd in: (2013-09-01)